Opportunities for isoporous membranes in the manufacture of genomic medicines

Viral and non-viral vectors have revolutionised in the last 5 years the approaches to tackling pandemics, cancers and genetic diseases. The intrinsic properties of these vectors present new separation challenges to their manufacture in terms of both the process-related impurities to be removed and t...

Full description

Bibliographic Details
Main Authors: Ke Meng, Thomas F. Johnson, Alberto Alvarez-Fernandez, Stefan Guldin, Daniel G. Bracewell
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:Journal of Membrane Science Letters
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772421223000168
_version_ 1797397574466928640
author Ke Meng
Thomas F. Johnson
Alberto Alvarez-Fernandez
Stefan Guldin
Daniel G. Bracewell
author_facet Ke Meng
Thomas F. Johnson
Alberto Alvarez-Fernandez
Stefan Guldin
Daniel G. Bracewell
author_sort Ke Meng
collection DOAJ
description Viral and non-viral vectors have revolutionised in the last 5 years the approaches to tackling pandemics, cancers and genetic diseases. The intrinsic properties of these vectors present new separation challenges to their manufacture in terms of both the process-related impurities to be removed and the complex labile nature of the target products. These characteristics make them susceptible to heterogeneity and the formation of product-related impurities.Conventional polyethersulfone membrane filters used for sterile filtration and ultrafiltration of viral vectors and lipid nanoparticles can display limited selectivity and cause product losses. To address these challenges, novel membrane materials and fabrication techniques to overcome the boundary of selectivity-permeability performance have become of interest. Isoporous membranes with well-defined pore size and pore dispersity at the nano-scale show promising separation performance but have only been demonstrated at small scales to date.This review summarises the decision process for the development of new membrane candidates for vector manufacturing in genomic medicine, including membranes fabricated by lithography, track-etched membranes, anodic aluminium oxide (AAO) membranes and self-assembled block copolymer membranes. By comparing these membranes to existing commercially available products, the possible advantages presented by novel materials and fabrication approaches are identified.
first_indexed 2024-03-09T01:12:04Z
format Article
id doaj.art-ca5a7f1542184264801d34222641c254
institution Directory Open Access Journal
issn 2772-4212
language English
last_indexed 2024-03-09T01:12:04Z
publishDate 2023-11-01
publisher Elsevier
record_format Article
series Journal of Membrane Science Letters
spelling doaj.art-ca5a7f1542184264801d34222641c2542023-12-11T04:17:39ZengElsevierJournal of Membrane Science Letters2772-42122023-11-0132100052Opportunities for isoporous membranes in the manufacture of genomic medicinesKe Meng0Thomas F. Johnson1Alberto Alvarez-Fernandez2Stefan Guldin3Daniel G. Bracewell4Department of Biochemical Engineering, Gower Street, University College London, London, WC1E 6BT, UKDepartment of Biochemical Engineering, Gower Street, University College London, London, WC1E 6BT, UKDepartment of Chemical Engineering, University College London, Torrington Place, London, WC1E 7HB, UKDepartment of Chemical Engineering, University College London, Torrington Place, London, WC1E 7HB, UKDepartment of Biochemical Engineering, Gower Street, University College London, London, WC1E 6BT, UK; Corresponding author at: Department of Biochemical Engineering, Gower Street, University College London, London, WC1E 6BT, UK.Viral and non-viral vectors have revolutionised in the last 5 years the approaches to tackling pandemics, cancers and genetic diseases. The intrinsic properties of these vectors present new separation challenges to their manufacture in terms of both the process-related impurities to be removed and the complex labile nature of the target products. These characteristics make them susceptible to heterogeneity and the formation of product-related impurities.Conventional polyethersulfone membrane filters used for sterile filtration and ultrafiltration of viral vectors and lipid nanoparticles can display limited selectivity and cause product losses. To address these challenges, novel membrane materials and fabrication techniques to overcome the boundary of selectivity-permeability performance have become of interest. Isoporous membranes with well-defined pore size and pore dispersity at the nano-scale show promising separation performance but have only been demonstrated at small scales to date.This review summarises the decision process for the development of new membrane candidates for vector manufacturing in genomic medicine, including membranes fabricated by lithography, track-etched membranes, anodic aluminium oxide (AAO) membranes and self-assembled block copolymer membranes. By comparing these membranes to existing commercially available products, the possible advantages presented by novel materials and fabrication approaches are identified.http://www.sciencedirect.com/science/article/pii/S2772421223000168Isoporous membranesGenomic medicineBio-separationUltrafiltrationBlock copolymer membranes
spellingShingle Ke Meng
Thomas F. Johnson
Alberto Alvarez-Fernandez
Stefan Guldin
Daniel G. Bracewell
Opportunities for isoporous membranes in the manufacture of genomic medicines
Journal of Membrane Science Letters
Isoporous membranes
Genomic medicine
Bio-separation
Ultrafiltration
Block copolymer membranes
title Opportunities for isoporous membranes in the manufacture of genomic medicines
title_full Opportunities for isoporous membranes in the manufacture of genomic medicines
title_fullStr Opportunities for isoporous membranes in the manufacture of genomic medicines
title_full_unstemmed Opportunities for isoporous membranes in the manufacture of genomic medicines
title_short Opportunities for isoporous membranes in the manufacture of genomic medicines
title_sort opportunities for isoporous membranes in the manufacture of genomic medicines
topic Isoporous membranes
Genomic medicine
Bio-separation
Ultrafiltration
Block copolymer membranes
url http://www.sciencedirect.com/science/article/pii/S2772421223000168
work_keys_str_mv AT kemeng opportunitiesforisoporousmembranesinthemanufactureofgenomicmedicines
AT thomasfjohnson opportunitiesforisoporousmembranesinthemanufactureofgenomicmedicines
AT albertoalvarezfernandez opportunitiesforisoporousmembranesinthemanufactureofgenomicmedicines
AT stefanguldin opportunitiesforisoporousmembranesinthemanufactureofgenomicmedicines
AT danielgbracewell opportunitiesforisoporousmembranesinthemanufactureofgenomicmedicines